-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 17, the CDE official website announced that BeiGene/BeiGene, Ltd.
According to public information, ZW25 (zanidatamab) is a bispecific antibody targeting HER2 introduced by BeiGene from Zymeworks for over US$400 million
As a bispecific antibody, ZW25 can simultaneously bind two non-overlapping HER2 epitopes, known as biparatopic binding